Pernicious anemia

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Pernicious anemia
Classification and external resources
ICD-10 D51.0
ICD-9 281.0
DiseasesDB 9870
MedlinePlus 000569
eMedicine med/1799 
MeSH D000752

WikiDoc Resources for

Pernicious anemia

Articles

Most recent articles on Pernicious anemia

Most cited articles on Pernicious anemia

Review articles on Pernicious anemia

Articles on Pernicious anemia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pernicious anemia

Images of Pernicious anemia

Photos of Pernicious anemia

Podcasts & MP3s on Pernicious anemia

Videos on Pernicious anemia

Evidence Based Medicine

Cochrane Collaboration on Pernicious anemia

Bandolier on Pernicious anemia

TRIP on Pernicious anemia

Clinical Trials

Ongoing Trials on Pernicious anemia at Clinical Trials.gov

Trial results on Pernicious anemia

Clinical Trials on Pernicious anemia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pernicious anemia

NICE Guidance on Pernicious anemia

NHS PRODIGY Guidance

FDA on Pernicious anemia

CDC on Pernicious anemia

Books

Books on Pernicious anemia

News

Pernicious anemia in the news

Be alerted to news on Pernicious anemia

News trends on Pernicious anemia

Commentary

Blogs on Pernicious anemia

Definitions

Definitions of Pernicious anemia

Patient Resources / Community

Patient resources on Pernicious anemia

Discussion groups on Pernicious anemia

Patient Handouts on Pernicious anemia

Directions to Hospitals Treating Pernicious anemia

Risk calculators and risk factors for Pernicious anemia

Healthcare Provider Resources

Symptoms of Pernicious anemia

Causes & Risk Factors for Pernicious anemia

Diagnostic studies for Pernicious anemia

Treatment of Pernicious anemia

Continuing Medical Education (CME)

CME Programs on Pernicious anemia

International

Pernicious anemia en Espanol

Pernicious anemia en Francais

Businness

Pernicious anemia in the Marketplace

Patents on Pernicious anemia

Experimental / Informatics

List of terms related to Pernicious anemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Pernicious anemia (also known as Biermer's anaemia or Addison's anaemia or Addison-Biermer anaemia) is a form of megaloblastic anaemia due to vitamin B12 deficiency dependent on impaired absorption of vitamin B12 in the setting of atrophic gastritis, and more specifically of loss of gastric parietal cells. While the term "pernicious anaemia" is sometimes also incorrectly used to indicate megaloblastic anaemia due to any cause of vitamin B12 deficiency, its proper usage refers to that caused by atrophic gastritis and parietal cell loss only.

Mechanisms & manifestations

Pathophysiology

Vitamin B12 cannot be produced by the human body, and must therefore be obtained from diet. Normally, dietary vitamin B12 can only be absorbed by the ileum when it is bound by the intrinsic factor produced by parietal cells of the gastric mucosa. In pernicious anaemia, this process is impaired because of loss of parietal cells, resulting in insufficient absorption of the vitamin, which over a prolonged period of time ultimately leads to vitamin B12 deficiency and thus megaloblastic anaemia.

Presentation

The presentation of pernicious anaemia resembles that of any other form of anaemia, but is often accompanied by the manifestations of vitamin B12 deficiency (notably neurological abnormalities such as peripheral neuropathy), as well as by other manifestations of autoimmune atrophic gastritis.

Causes

Most commonly, the cause for impaired binding of vitamin B12 by intrinsic factor is autoimmune atrophic gastritis, in which autoantibodies are directed against parietal cells (resulting in their loss) as well as against the intrinsic factor itself (rendering it unable to bind vitamin B12). Less frequently, loss of parietal cells may simply be part of a widespread atrophic gastritis of non-autoimmune origin, such as that frequently occurring in elderly people affected with long-standing chronic gastritis of any cause (including Helicobacter pylori infection). Note that forms of vitamin B12 deficiency other than pernicious anaemia must be considered in the differential diagnosis of megaloblastic anaemia.

Diagnosis

A diagnosis of pernicious anaemia first requires demonstration of megaloblastic anaemia (through a full blood count) and of its direct cause, vitamin B12 deficiency (by measuring B12 levels in serum). A Schillings test can then be used to distinguish pernicious anemia from other causes of vitamin B12 deficiency (notably malabsorption. A diagnosis of atrophic gastritis should be confirmed by gastroscopy with biopsies. Approximately 90% of individuals with pernicious anemia have antibodies for parietal cells, however only 50% of individuals with these antibodies have pernicious anaemia.

Pathology

B12 anemia (pernicious), megaloblastic anemia, hypersegs
B12 anemia (pernicious), megaloblastic anemia, hypersegs[1]


Treatment

Being a manifestation of vitamin B12 deficiency, pernicious anaemia is treated by administering vitamin B12 supplements. Note that if oral tablets are chosen for this purposes, much higher doses are given than normally required in order to overcome the impaired absorption that characterises pernicious anaemia. If oral tablets are not sufficient, vitamin B12 can also be administered via injection. Often the patient can learn to do this at home.

History

The treatment for pernicious anemia was first devised by George Whipple who bled dogs to make them anemic and then fed them various substances to see what (if anything) would make them healthy again. He discovered that ingesting large amounts of liver seemed to cure the disease. George Minot and William Murphy then set about to chemically isolate the curative substance and ultimately were able to isolate the vitamin B12 from the liver. For this, all three shared the 1934 Nobel Prize in Medicine. As a result, pernicious anemia is now treated with either vitamin B12 injections, or large oral doses of vitamin B12, typically between 2 and 4 mg daily.

Famous sufferers

  • Inez Milholland, American Suffragette.
  • Alexander Graham Bell, Scottish scientist and inventor.
  • Annie Oakley.
  • Norman Warne, Editor/Publisher & fiance of Beatrix Potter.
  • Yoon Eun Hye, A South Korean actress

External links

de:Perniziöse Anämieit:Anemia perniciosa

nl:Pernicieuze anemiefi:Pernisiöösi anemia

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
In other languages